Sectors
IRD
Opus Genetics, Inc.
3.62
1 x 3.58
2 x 4.68
bid
ask
-
0.07
1.90%
2 @ 06:40 PM
3.77 +0.15 (4.14%)
| Ytd | 80.10% | |
| 1y | 196.72% |
3.51
day range
3.72
1.22
52 week range
5.81
| Open | 3.71 | Prev Close | 3.69 | Low | 3.51 | High | 3.72 | Mkt Cap | 301.17M |
| Vol | 574.90K | Avg Vol | 967.11K | EPS | -1.29 | P/E | N/A | Forward P/E | -1.20 |
| Beta | 0.59 | Short Ratio | 4.69 | Inst. Own | 8.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 3.74 | 200-d Avg | 3.64 | 1yr Est | 10.50 |
| Income Statement | |||
| Total Revenue | 755.00K | ||
| Revenues (USD) | 755.00K | ||
| Gross Profit | 755.00K | ||
| Operating Expenses | 17.24M | ||
| Research and Development Expense | 11.21M | ||
| Selling, General and Administrative Expense | 6.03M | ||
| Operating Income | -16.48M | ||
| Net Income | -8.10M | ||
| Net Income Common Stock | -8.10M | ||
| Net Income Common Stock (USD) | -8.10M | ||
| Consolidated Income | -8.10M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -8.10M | ||
| Earning Before Interest & Taxes (USD) | -8.10M | ||
| Weighted Average Shares | 95.48M | ||
| Weighted Average Shares Diluted | 111.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 88.91M | ||
| Cash and Equivalents (USD) | 88.91M | ||
| Trade and Non-Trade Receivables | 1.46M | ||
| Current Assets | 92.70M | ||
| Property, Plant & Equipment Net | 172.00K | ||
| Total Assets | 92.97M | ||
| Total Debt | 34.93M | ||
| Current Liabilities | 7.61M | ||
| Debt Non-Current | 34.93M | ||
| Total Liabilities | 105.95M | ||
| Accumulated Retained Earnings (Deficit) | -262.22M | ||
| Shareholders Equity | -12.99M | ||
| Shareholders Equity (USD) | -12.99M | ||
| Assets Non-Current | 272.00K | ||
| Total Debt (USD) | 34.93M | ||
| Liabilities Non-Current | 98.35M | ||
| Trade and Non-Trade Payables | 1.88M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.00K | ||
| Net Cash Flow from Financing | 40.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 28.95M | ||
| Issuance (Purchase) of Equity Shares | 5.48M | ||
| Issuance (Repayment) of Debt Securities | 35.00M | ||
| Net Cash Flow from Operations | -11.95M | ||
| Share Based Compensation | 1.41M | ||